Brief: Day One Reports First Quarter 2023 Financial Results And Corporate Progress

Day One Biopharmaceuticals

01/05/2023 14:40

May 1 (Reuters) - Day One Biopharmaceuticals Inc
 DAWN.O :
    * DAY ONE REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
CORPORATE PROGRESS
    * DAY ONE BIOPHARMACEUTICALS INC - QTRLY LOSS PER SHARE
$0.59

Source text for Eikon:  ID:nGNXbWRScs 
Further company coverage:  DAWN.O 

 ((Reuters.Briefs@thomsonreuters.com;))